Literature DB >> 27899080

Erratum to: 53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cells.

Ruoxi Hong1,2, Fei Ma1, Weimin Zhang3, Xiying Yu3, Qing Li1, Yang Luo1, Changjun Zhu4, Binghe Xu5, Wei Jiang6.   

Abstract

Entities:  

Year:  2016        PMID： 27899080      PMCID： PMC5129646          DOI： 10.1186/s12885-016-2970-1

Source DB:  PubMed          Journal:  BMC Cancer        ISSN： 1471-2407            Impact factor:   4.430


× No keyword cloud information.

Erratum

After the publication of the article [1], the authors realised that the corresponding authors’ order need to be changed. Details as follows: Correct corresponding author order: Binghe Xu1* and Wei Jiang3* Correct correspondence: xubinghe@medmail.com.cn; wjiang6138@cicams.ac.cn Please note that the above author list and corresponding emails have been updated.
  1 in total

1.  53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cells.

Authors:  Ruoxi Hong; Fei Ma; Weimin Zhang; Xiying Yu; Qing Li; Yang Luo; Changjun Zhu; Wei Jiang; Binghe Xu
Journal:  BMC Cancer       Date:  2016-09-09       Impact factor: 4.430
  1 in total
  3 in total

1.  A comparative cost analysis of transanal and laparoscopic total mesorectal excision for rectal cancer.

Authors:  Francesca Di Candido; Michele Carvello; Deborah S Keller; Elena Vanni; Annalisa Maroli; Isacco Montroni; Roel Hompes; Matteo Sacchi; Marco Montorsi; Antonino Spinelli
Journal:  Updates Surg       Date:  2020-09-14

2.  Transanal total mesorectal excision outcomes for advanced rectal cancer in a complex surgical population.

Authors:  Ivy H Gardner; Katherine A Kelley; Walaa F Abdelmoaty; Ahmed Sharata; Amanda V Hayman; Mark H Whiteford
Journal:  Surg Endosc       Date:  2021-01-08       Impact factor: 4.584

3.  Transanal total mesorectal excision for stage II or III rectal cancer: pattern of local recurrence in a tertiary referral center.

Authors:  Carolina González-Abós; F Borja de Lacy; Yoelimar Guzmán; Sara T Nogueira; Ana Otero-Piñeiro; Raúl Almenara; Antonio M Lacy
Journal:  Surg Endosc       Date:  2021-01-04       Impact factor: 4.584
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.